quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:19:10·947d
NEWSRelease
AgileThought Inc. logo
Avinger Inc. logo
Bird Global Inc. logo
+16

Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket

AGIL· AgileThought Inc.AVGR· Avinger Inc.BRDS· Bird Global Inc.CCG· Cheche Group Inc.CNXA· Connexa Sports Technologies Inc.CYBN· Cybin Inc.
Consumer DiscretionaryHealth CareFinance
Original source

Companies

  • AGIL
    AgileThought Inc.
    Consumer Discretionary
  • AVGR
    Avinger Inc.
    Health Care
  • BRDS
    Bird Global Inc.
    Consumer Discretionary
  • CCG
    Cheche Group Inc.
    Finance
  • CNXA
    Connexa Sports Technologies Inc.
    Consumer Discretionary
  • CYBN
    Cybin Inc.
    Health Care
  • DTOC
    Digital Transformation Opportunities Corp.
    Health Care
  • EBET
    EBET INC.
    Consumer Discretionary
  • ELUT
    Elutia Inc.
    Health Care
  • EXAI
    Exscientia Plc
    Health Care
  • FRTX
    Fresh Tracks Therapeutics Inc.
    Health Care
  • GLG
    TD Holdings Inc.
    Technology
  • HSTO
    Histogen Inc.
    Health Care
  • IKT
    Inhibikase Therapeutics Inc.
    Health Care
  • MBOT
    Microbot Medical Inc.
    Health Care
  • RNAZ
    TransCode Therapeutics Inc.
    Health Care
  • RVNC
    Revance Therapeutics Inc.
    Health Care
  • RVSN
    Rail Vision Ltd.
    Industrials
  • SPRY
    ARS Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Apr 9SPRYUpdateNorthland Capital$25.00
  • Mar 4IKTUpdateLadenburg Thalmann$4.00
  • Feb 10MBOTUpdateB. Riley Securities$5.00
  • Jan 21IKTUpdateBofA Securities$6.00
  • Dec 26IKTUpdateH.C. Wainwright$8.00
  • Dec 11IKTUpdateCantor Fitzgerald$4.00

Related

  • SEC1d
    SEC Form DEFA14A filed by Elutia Inc.
  • SEC1d
    SEC Form DEF 14A filed by Elutia Inc.
  • SEC2d
    Microbot Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR2d
    Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
  • SEC3d
    SEC Form SCHEDULE 13G filed by TransCode Therapeutics Inc.
  • SEC3d
    SEC Form PRE 14A filed by Inhibikase Therapeutics Inc.
  • SEC8d
    SEC Form 10-K filed by TransCode Therapeutics Inc.
  • PR9d
    neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022